Summary
Samples of 96 polyvalent and virus-specific immunoglobulin batches commercially available in West-Germany were tested by enzyme-linked immunoassay and immunoblot for the presence of anti-HTLV-III antibodies. 37% of the polyvalent and 87% of the virus-specific batches were positive. It was concluded that these preparations are still safe and because of their reportedly low titer neutralizing antibodies possibly beneficial in certain cases, such as newborns of HTLV-III positive mothers or after accidental exposure to infectious material in clinics or laboratories.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AIDS:
-
acquired immunodeficiency syndrome
- ARC:
-
AIDS-related complex
- CMV:
-
cytomegalovirus
- ELISA:
-
enzyme-linked immuno adsorbent assay
- HTLV-III:
-
human T-cell lymphotropic virus, type III
References
Ho DD, Rota TR, Hirsch MS (1985) Antibody to lymphadenopathy — associated virus in AIDS. New Engl J Med 312:649–650
Kurth R, Mikschy U, Tondera Ch, Lizonová A, Brede HD, Helm EB, Bergmann L, Frank H, Popovic M, Gallo RC (1984) HTLV-III Infektionen bei Patienten mit AIDS und Lymphadenopathie-Syndrom. Münch med Wochenschr 126:1363–1368
Kurth R, Mikschy U, Werner A, von Wangenheim G, Fischer H, Löwer J, Brede HD (1985) Methoden zum Nachweis von HTLV-III Infektionen. Med Verlagsgesellschaft, Marburg, pp 23–30
Robert-Guroff M, Brown M, Gallo RC (1985) HTLV-III neutralizing antibodies in patients with AIDS and AIDS-related Complex. Nature 316:72–74
Saxinger C, Gallo RC (1983) Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human T-cell leukemia-lymphoma virus. Lab Invest 49:371–379
Schneider W, Kaiser PE (1981) Immunoglobulin vom Menschen — Anforderungen an seine Unschädlichkeit und Wirksamkeit. Immun Infekt 9:157–161
Weeke-Lüttman M, Schmidt I, Fenyves A, von Wangenheim G, Fischer L (1984) Neutralisierende Antikörper in humanen Immunglobulinen zur intravenösen Anwendung. Immun Infekt 12:201–207
Weiss RA, Clapham PR, Cheingsong-Popov R, Dalgleich AG, Carne ChA, Weller IVD, Tedder RS (1985) Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature 316:69–71
Harada S, Koyanagi Y, Yamamoto N (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563–566
Update (1985) Prospective evaluation of health-care workers exposed via the parenteral or mucous-membrane route to blood or body fluids from patients with acquired immunodeficiency syndrome. Morb Mort Weekly Rep 34:101–103
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kurth, R., Schmidt, I., Werner, A. et al. Detection of antibodies to HTLV-III in commercially available immunoglobulin preparations. Klin Wochenschr 64, 386–388 (1986). https://doi.org/10.1007/BF01728189
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01728189